Page last updated: 2024-11-08

pentylenetetrazole and Uterine Rupture

pentylenetetrazole has been researched along with Uterine Rupture in 1 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Uterine Rupture: A complete separation or tear in the wall of the UTERUS with or without expulsion of the FETUS. It may be due to injuries, multiple pregnancies, large fetus, previous scarring, or obstruction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BALTZER, H1
SCHUMACHER, U1

Other Studies

1 other study available for pentylenetetrazole and Uterine Rupture

ArticleYear
[ON THE USE OF THE "O.-C."-"T.-C."-"S.-C."-METHOD (I.V. MIXTURE OF ORASTHIN, TOKOFINAL OR SYNTOCINON WITH CARDIAZOL) FOR LABOR ACCELERATION IN TWIN DELIVERIES AND THE RELATION OF THIS TYPE OF DELIVERY TO UTERINE RUPTURE].
    Geburtshilfe und Frauenheilkunde, 1964, Volume: 24

    Topics: Delivery, Obstetric; Female; Humans; Labor, Obstetric; Obstetric Labor Complications; Oxytocics; Oxy

1964